Just to clarify, when I say "but they can probably skip those and go straight to the FDA" I mean they could probably skip making Announcements about receiving Ethics Approval and about Toxicology Studies. They can't skip the step of seeking Ethics Approval for a Clinical Trial or the step of undertaking Toxicology Studies (which we already know are either happening or complete). They certainly have to do them, but they could just skip Announcing the results of both because, in the end, it is only the IND status outcome which is the real market sensitive outcome.
Cheers
Dave
Just to clarify, when I say "but they can probably skip those...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
-0.001(1.72%) |
Mkt cap ! $420.8M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.9¢ | 5.7¢ | $650.0K | 11.29M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 761253 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 866630 | 23 |
View Market Depth
| Last trade - 12.51pm 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.6¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 5.7¢ | 5.8¢ | 5.6¢ | 6327778 | ||
| Last updated 13.09pm 18/06/2024 ? | |||||
| IMU (ASX) Chart |